• CHMP recommends AstraZeneca’s Qtrilmet for type 2 diabetes pharmaceutical-technology
    September 25, 2019
    The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the marketing authorisation of AstraZeneca’s Qtrilmet to treat type 2 diabetes in adults.
  • EMA CHMP recommends seven medicines for approval europeanpharmaceuticalreview
    September 25, 2019
PharmaSources Customer Service